Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

New Options on the Horizon for C diff Prevention

SEP 28, 2018 | CONTAGION® EDITORIAL STAFF


Segment Description:  Dale N Gerding, MD, research physician, Edward Hines Jr. VA Hospital, provides insight about prevention options for C diff that are expected in the future.

Interview transcript: (modified slightly for readability):

The[re are a few] prevention and treatment options, that are coming, we hope, in the future. For prevention—vaccines. Vaccines are currently—at least 1 of them—in phase 3 trials. One recently had its phase 3 trial stopped, which is disappointing, but that’s one possibility. The use of monoclonal antibody is a passive immune strategy that will likely help prevent recurrent C diff.

And then there are a number of strategies that are manipulating the microbiome that potentially, in the future, could be used as preventative strategies. One of those is the use of non-toxigenic C diff, which could colonize patients and prevent them from getting C diff in the future, and this is a short-term preventative strategy that should be effective for 1 to 2 months.”


 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can